Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Productivity Products 140

Innovation Excellence

APRIL 20, 2020

COVID19 will change the way we behave, conduct business, and indeed how we innovate for years to come. But how can the innovation community help nudge us in that direction in the face of inevitable economic and social challenges? The good news is that without tough problems, we wouldn’t need innovation, so this is an opportunity.

Innovation 73

Innovation Supply Chain Crisis Short-term 73

The Horizons Tracker

NOVEMBER 23, 2020

The coronavirus pandemic has thrust the healthcare and pharmaceutical industries into the limelight like never before. It’s a prominence that new research from Novartis suggests has created a fresh allure for the industry in the eyes of the best tech talent on the market. Driving change.

Industry 99

Industry Pharmaceuticals Technology Finance 99

The Horizons Tracker

SEPTEMBER 21, 2023

New markets The data implies a lively market for CEOs, enticed by the prospect of elevated remuneration, reduced public scrutiny, and the operational proficiency that private equity (PE) firms offer. You’ve got to learn the specifics of the company, but it’s not as hard as you think,” the researchers explain.

Press Release 114

Press Release CEO Pharmaceuticals Industry 114

Talent Anarchy 1

AUGUST 25, 2023

In today’s ever-evolving job market, individuals are constantly on the lookout for career paths that promise stability, growth, and fulfillment. Pharmaceuticals: Medicines and healthcare products are also considered consumer non-durables. This includes advertising campaigns, social media marketing, and product launches.

Career 60

Career Supply Chain Pharmaceuticals Industry 60

The Horizons Tracker

SEPTEMBER 15, 2019

model, which is supported by the Estonian government, demonstrates the paths to new business models that focus not only on providing services, but also on fostering a collaborative platform for all to innovate. The E-Residency initiative and its succeeding 2.0

Pharmaceuticals 69

Pharmaceuticals Entrepreneur Politics Globalization 69

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Coaching Tip

MARCH 15, 2011

Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Power Long-term 84

The Horizons Tracker

FEBRUARY 22, 2022

It’s a market that is already worth $3.1 billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. “ There are cases with upload speeds of over 1Gbps.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 54

Pharmaceuticals Transportation Retail Long-term 54

Strategy Driven

JUNE 22, 2018

By adapting your marketing strategy, you will be able to target new audiences for your products and services. Let’s look at the niche markets that you can tap into boost your business’s growth and profitability: Seniors. When marketing for seniors you need to pay great attention to the content that you produce, especially online.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

SEPTEMBER 15, 2011

What they found is that America's patent system only provides positive incentives for innovation in two industries: pharmaceuticals and chemicals. Anyone innovating outside of those two industries would be better off if there were no patent system at all.

Innovation 15

Innovation Chemicals Incentives Pharmaceuticals 15

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Displacement generally is easier to combat than disruption. This presents Western companies with a fresh challenge.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 15

Innovation P&L Short-term Company 15

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 13

Globalization Innovation Decentralization Chemicals 13

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. Older people need more medicine. Read More from the Government of Japan.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Leading Blog

NOVEMBER 15, 2024

New technologies, shifting regulations, and a heightened focus on biotechnology and pharmaceuticals meant that professionals needed to stay ahead of the curve. I saw a gap in the market—a demand for comprehensive, high-quality training that could empower individuals and drive progress in the industry.

Uncertainty 380

Uncertainty Biotechnology Industry Training 380

Harvard Business Review

JUNE 7, 2012

The numbers are enough to make the apple pop right out of the marketer's eye. Clearly that's not quite the target market for a new washer and dryer. Medical supply and equipment costs are abating under market pressure. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 15

Disruptive Innovation Innovation Pharmaceuticals Class 15

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 10

Cost Innovation Wireless Disruptive Innovation 10

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences. They were correct.

Pharmaceuticals 16

Pharmaceuticals Strategy Advertising Price 16

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. For example, Sproxil has found pharmaceutical buyers for its anti-drug counterfeiting service. There are now more than 5.3

Wireless 16

Wireless Health Care Pharmaceuticals Business Model 16

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 15

Pharmaceuticals Banking Chemicals Entrepreneur 15

Harvard Business Review

MAY 26, 2016

While a dynamic, competitive economy rewards innovative firms with high profits and punishes poor performers with low profits, sustained aggregate profits suggest, instead, that firms are able to get away with higher prices because competition is limited. If so, then high profits portend diminished productivity growth.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. Then to your credit, you bring up the paradox yourself.

Supply Chain 17

Supply Chain Open-book Software Niche Marketing 17

Harvard Business Review

SEPTEMBER 19, 2013

Previously untapped markets drive financial returns. New problem-solving innovators and investors power this solution economy. They range from Ashoka , which deploys 3,000 citizen changemakers in 70 countries, to the global pharmaceutical giants that annually give away billions of dollars in medicine to low-income citizens.

Pharmaceuticals 15

Pharmaceuticals Marketing Politics Bottom-up 15

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. The culture at GE, for example, centers on execution, simplicity, and innovation.

Leadership Pipeline 15

Leadership Pipeline Leadership After Action Review Pharmaceuticals 15

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity.

Globalization 13

Globalization Supply Chain Pharmaceuticals McKinsey 13

Harvard Business Review

APRIL 16, 2012

Strategic cash provides more flexibility concerning the timing and pricing of potential acquisitions; having cash on hand is the best insurance that CFOs will be able to respond with alacrity to opportunities and not be subject to the vagaries of the financial markets. Facilitate Investments. Arguments Against Strategic Cash.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Financial institutions must find innovative ways to understand their consumers' aspirations and actual behavior.

Banking 14

Banking Pharmaceuticals Microfinance Risk Management 14

Harvard Business Review

FEBRUARY 26, 2018

Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. “To be able to do that, they need to entice companies to come to Japan, and they need to entice their own pharmaceutical companies to license in and obtain the best.” Agilis Biotherapeutics, a U.S.

Pharmaceuticals 8

Pharmaceuticals Content Licensing Trends 8